EU-Investitionsoffensive: EIB unterstützt italienischen Entwickler von ZNS-Therapeutika Newron Pharmaceuticals mit bis zu EUR 40 Mio.

The European Commission has approved an investment package of €243 million from the EU budget for projects under the LIFE programme supporting nature, the environment and quality of life in Europe’s transition to a more sustainable and low-carbon future.